← Leaderboards
Daniel De Carvalho
University Health Network
$786,223
Attributed
$1,572,445
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $410.4K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,572,445 · 1
By mechanism
R01$1,572,445 · 1
Top collaborators
- Gelareh Zadeh4 shared
Most similar at University Health Network
Same institution · by research overlap
- Gelareh Zadeh$786,223
Others in their field
Other Rising Stars on “Dna Analysis”
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Maximilian Haeussler · University Of California Santa Cruz$12,592,563
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
- Mariet Allen · Mayo Clinic Jacksonville$9,602,417
- James Cappo · National Jewish Health$9,298,220
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
Research focus
Dna AnalysisDna MethylationCohortDiscriminationDiagnosisBlood TestsAntibodiesAccurate DiagnosisBiological MarkersDifferential DiagnosisBlood CirculationAnxietyCell Free DnaCellsBrainCentral Nervous System NeoplasmsBrain MassCerebrospinal FluidCirculating DnaBrain NeoplasmsBrain SurgeryClassificationClinical DiagnosisDna Methylation Profiling
Grant awards (4)
Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors$391,675
R01 · FY2025 · CA
Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors$370,260
R01 · FY2024 · CA
Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors$400,069
R01 · FY2023 · CA
Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors$410,441
R01 · FY2022 · CA